Please login to the form below

Not currently logged in
Email:
Password:

Aesica creates commercial MD role

Appoints Catalent’s Ian Muir to new position

Aesica has named Ian Muir as the company's first commercial managing director, effective February 24.

The contract development and manufacturing (CDMO) firm Aesica said the creation of the role reflects the company's decision to focus on 'core commercial activities'.

Muir's responsibilities will cover manufacture of active pharmaceutical ingredients, formulation development and formulated products, while he will also lead the expansion of the business into new markets, such as China and Japan.

He joins from the CDMO Catalent where he was responsible for the global provision of contract development and manufacturing services for oral dose forms.

Muir's previous experience also includes commercial responsibilities in the US, Australia and Japan.

Aesica's CEO Robert Hardy said: “Ian brings strong commercial business knowledge and has proven experience of delivering growth and will play a pivotal role in driving further business growth for Aesica across API, formulation development and formulated products.”

5th February 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 women leaders in UK healthcare (part 3)
Part 3 of our list of thirty women leaders...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics